Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26523647 | 0.95 | — | — | |
| SCHEMBL26523635 | 0.92 | — | — | |
| SCHEMBL26523678 | 0.90 | ERBB2 (0.33) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL26523650 | 0.90 | — | — | |
| SCHEMBL26523675 | 0.88 | CYP1A2 (0.42) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL26523896 | 0.87 | ERBB2 (0.30) | ERBB2CYP1A2FYNMAOAACHE | |
| SCHEMBL26523663 | 0.84 | — | — | |
| SCHEMBL26523938 | 0.83 | — | — | |
| SCHEMBL26523671 | 0.82 | — | — | |
| SCHEMBL26523869 | 0.82 | ERBB2 (0.30) | ERBB2CYP1A2FYNMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329110-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329110-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329110-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | FOXO3, ORC3, ORAI3 | ERBB2 2640/4885CYP1A2 2352/4885FYN 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.